John W. LaRocca
Overview
John W. LaRocca received an average of $2M in total compensation, including $421K in salary, at Aerie Pharmaceuticals from 2018 to 2021.
Source: SEC filings on April 26, 2022, April 27, 2021, April 24, 2020, and April 10, 2019.
Related executives
We found ten more executives who work or worked at Aerie Pharmaceuticals.
Vicente Anido
Aerie Pharmaceuticals
Chief Executive Officer
Raj Kannan
Aerie Pharmaceuticals
Chief Executive Officer
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
Casey Kopczynski
Aerie Pharmaceuticals
Chief Innovation Officer, Head of Research and External Innovation
Benjamin McGraw
Aerie Pharmaceuticals
Former Interim Executive Chair
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
Christopher Staten
Aerie Pharmaceuticals
Chief Financial Officer
David Hollander
Aerie Pharmaceuticals
Chief Research and Development Officer
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019